BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 1310708)

  • 1. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow.
    Jagels MA; Hugli TE
    J Immunol; 1992 Feb; 148(4):1119-28. PubMed ID: 1310708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
    O'Flaherty JT
    J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals.
    Desaulniers P; Marois S; Paré G; Popa-Nita O; Gilbert C; Naccache PH
    J Rheumatol; 2006 May; 33(5):928-38. PubMed ID: 16652423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of acute inflammatory lesions to chemotaxins and endotoxin.
    Colditz IG; Movat HZ
    J Immunol; 1984 Oct; 133(4):2163-8. PubMed ID: 6088633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
    Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
    Wirthmueller U; De Weck AL; Dahinden CA
    J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils.
    Kajita T; Hugli TE
    Am J Pathol; 1990 Aug; 137(2):467-77. PubMed ID: 2386204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a.
    Wirthmueller U; Baggiolini M; de Weck AL; Dahinden CA
    Biochem Biophys Res Commun; 1991 May; 176(3):972-8. PubMed ID: 1645549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes.
    Ulich TR; del Castillo J; Keys M; Granger GA; Ni RX
    J Immunol; 1987 Nov; 139(10):3406-15. PubMed ID: 3316383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation.
    Hechtman DH; Cybulsky MI; Fuchs HJ; Baker JB; Gimbrone MA
    J Immunol; 1991 Aug; 147(3):883-92. PubMed ID: 1650387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of superoxide anion and hydrogen peroxide by human neutrophilic granulocytes during chemotactic migration towards f-Met-Leu-Phe, C5a, leukotriene B4, monocyte-derived chemotaxin/IL-8 and platelet-activating factor.
    Kownatzki E; Uhrich S
    Int Arch Allergy Appl Immunol; 1990; 93(4):344-9. PubMed ID: 1966131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migratory responses of ovine neutrophils to inflammatory mediators in vitro and in vivo.
    Mulder K; Colditz IG
    J Leukoc Biol; 1993 Mar; 53(3):273-8. PubMed ID: 8384237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.